1 March 2012
A new drug is set to limit the amount of brain damage which occurs when a person suffers a stroke.
Scientists at the Toronto Western Research Institute (TWRI), Krembil Neuroscience Center, have developed the treatment, which could help those who require a brain scan over concerns for their mental and long-term health following a stroke.
The drug stands out for being able to offer a neuroprotective effect to aid the brain when a person is subjected to the serious health condition.
Dr Michael Tymianski, the lead author of the study and a senior scientist at TWRI, noted: "We are closer to having a treatment for stroke than we have ever been before."
Further details of the drug's development, which is being called a PSD95 inhibitor, have been revealed in an article published in the journal Nature.
In a similar study, researchers at the University of Copenhagen have created a chemical compound which could significantly reduce the brain damage which is recorded after a person is struck down by a stroke.
Posted by Philip Briggs
Tymianski, Michael. 'Treatment of Stroke with a PSD95 inhibitor in the Gyrencephalic Primate Brain'. Nature. Wednesday February 29th 2012.
Health News is provided by Adfero in collaboration with Spire Healthcare. Please note that all copy above is ©Adfero Ltd. and does not reflect views or opinions of Spire Healthcare unless explicitly stated. Additional comments on the page from individual Spire consultants do not necessarily reflect the views or opinions of other consultants or Spire Healthcare.